Xavier Matias-Guiu Guia

Bosse, T; Lax, S; Abu-Rustum, N; Matias-Guiu, X

The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 40 102-110. 01/03/2021.

[doi:10.1097/PGP.0000000000000755]

Jan van Weelden W; Reijnen C; Küsters-Vandevelde HVN; Bulten J; Bult P; Leung S; Visser NCM; Santacana M; Bronsert P; Hirschfeld M; Colas E; Gil-Moreno A; Reques A; Mancebo G; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; Snijders MPLM; Matias-Guiu X; Amant F; Krakstad C; van de Vijver K; McAlpine J; Pijnenborg J; ENITEC-consortium

The cut-off for estrogen and progesterone receptor in endometrial cancer revisited: an ENITEC collaboration study.

HUMAN PATHOLOGY 109 80-91. 01/03/2021.

[doi:10.1016/j.humpath.2020.12.003]

Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Martin AG; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

RADIOTHERAPY AND ONCOLOGY 154 327-353. 01/03/2021.

[doi:10.1016/j.radonc.2020.11.018]

Frias-Gomez J; Peremiquel-Trillas P; Alemany L; Ameijide A; Marcos-Gragera R; Ponce J; Brunet J; Matias-Guiu X; Galceran J; Izquierdo Á; Borràs JM; Costas L; Clèries R

Predicting the rising incidence and mortality of endometrial cancers among women aged 65-74 years in Catalonia.

MATURITAS 144 11-15. 01/02/2021.

[doi:10.1016/j.maturitas.2020.09.006]

Concin N; Creutzberg CL; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann JA; Bosse T; Chargari C; Fagotti A; Fotopoulou C; González-Martín A; Lax SF; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell DE; Querleu D; Raspollini MR; Sehouli J; Sturdza AE; Taylor A; Westermann AM; Wimberger P; Colombo N; Planchamp F; Matias-Guiu X

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

VIRCHOWS ARCHIV 478 153-190. 01/02/2021.

[doi:10.1007/s00428-020-03007-z]

Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Gonzalez Martin A; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 31 12-39. 01/01/2021.

[doi:10.1136/ijgc-2020-002230]

MATIAS-GUIU GUIA, XAVIER

Endometrial Cancer Histopathology Reporting Guide

Endometrial Cancer Histopathology Reporting Guide -. 01/01/2021.

Romero I; Rubio MJ; Medina M; Matias-Guiu X; Santacana M; Schoenenberger JA; Guerra EM; Cortés A; Minig L; Coronado P; Cueva JF; Gómez L; Malfettone A; Sampayo M; Llombart-Cussac A; Poveda A

An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.

GYNECOLOGIC ONCOLOGY 159 721-731. 01/12/2020.

[doi:10.1016/j.ygyno.2020.09.013]

Miller RE; Leary A; Scott CL; Serra V; Lord CJ; Bowtell D; Chang DK; Garsed DW; Jonkers J; Ledermann JA; Nik-Zainal S; Ray-Coquard I; Shah SP; Matias-Guiu X; Swisher EM; Yates LR

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.

ANNALS OF ONCOLOGY 31 1606-1622. 01/12/2020.

[doi:10.1016/j.annonc.2020.08.2102]

Mellid S; Coloma J; Calsina B; Monteagudo M; Roldán-Romero JM; Santos M; Leandro-García LJ; Lanillos J; Martínez-Montes ÁM; Rodríguez-Antona C; Montero-Conde C; Martínez-López J; Ayala R; Matias-Guiu X; Robledo M; Cascón A

Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.

Cancers 12 1-12. 09/11/2020.

[doi:10.3390/cancers12113304]

Rodriguez-Hernandez I; Maiques O; Kohlhammer L; Cantelli G; Perdrix-Rosell A; Monger J; Fanshawe B; Bridgeman VL; Karagiannis SN; Penin RM; Marcolval J; Marti RM; Matias-Guiu X; Fruhwirth GO; Orgaz JL; Malanchi I; Sanz-Moreno V

WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.

Nature Communications 11 5315-5315. 20/10/2020.

[doi:10.1038/s41467-020-18951-2]

Cuatrecasas M; Gorostiaga I; Riera C; Saperas E; Llort G; Costa I; Matias-Guiu X; Carrato C; Navarro M; Pineda M; Dueñas N; Brunet J; Marco V; Trias I; Busteros JI; Mateu G; Balaguer F; Fernández-Figueras MT; Esteller M; Musulén E

Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal Neoplasia.

Cancers 12 1-20. 29/09/2020.

[doi:10.3390/cancers12102803]